Participants may not have a dependency on IV hydration or total parenteral nutrition (TPN)
Subjects with clinical symptoms or signs of gastrointestinal obstruction and/or who require drainage gastrostomy tube and/or parenteral hydration or nutrition.
Patients with clinical symptoms or signs of gastrointestinal obstruction and who require parenteral hydration and/or nutrition
Participant may not have a percutaneous endoscopic gastrostomy (PEG) tube or be receiving total parenteral nutrition (TPN)
Patient has an inability to swallow oral medications; Note: patient may not have a percutaneous endoscopic gastrostomy (PEG) tube or be receiving total parenteral nutrition (TPN)
Current dependency on intravenous (IV) hydration or total parenteral nutrition (TPN)
Patients requiring IV hydration or parenteral nutrition
Patients must not require total parenteral nutrition with lipids
Patients may not have current dependency on intravenous (IV) hydration or total parenteral nutrition (TPN)
Dependency on IV hydration or total parenteral nutrition (TPN)
Participant has clinical symptoms or signs of partial or complete gastrointestinal obstruction or, requires parenteral hydration and/or nutrition
Current dependency on total parenteral nutrition or IV fluid hydration.
Clinical or radiographic evidence of bowel obstruction, or need for parenteral hydration and/or nutrition
Requirement for chronic parenteral hydration/nutrition
PHASE I STUDY ELIGIBILITY CRITERIA:\r\nCurrent dependency on total parenteral nutrition (TPN) or IV fluid hydration
PHASE II COLORECTAL CANCER COHORT 6 (MEDI+C ONLY):\r\nCurrent dependency on total parenteral nutrition (TPN) or IV fluid hydration
Dependency on intravenous (IV) hydration or total parenteral nutrition (TPN)
Patients must not require total parenteral nutrition with lipids
Nutrition evaluation with consideration of percutaneous endoscopic gastrostomy (PEG) tube placement
Ongoing use of total parental nutrition
Patients with clinical symptoms of gastrointestinal obstruction and who require parenteral hydration/nutrition
Patient has an inability to swallow oral medications; Note: Patient may not have a percutaneous endoscopic gastrostomy (PEG) tube or be receiving total parenteral nutrition (TPN)
Patient has an inability to swallow oral medications and patients with gastrointestinal disorders likely to interfere with absorption of the study medication. Note: Patient may not have a percutaneous endoscopic gastrostomy (PEG) tube or be receiving total parenteral nutrition (TPN).
Gastrointestinal disorders that may interfere with absorption of oral agents, such as malabsorption syndromes; additionally, patients requiring drainage gastrostomy (e.g. percutaneous endoscopic gastrostomy [PEG] tube) and/or parenteral hydration and/or nutrition support are not eligible
Dependency on IV hydration or total parenteral nutrition (TPN)
No current dependency on intravenous (IV) hydration or total parental nutrition (TPN)
Patients with clinical symptoms or signs of gastrointestinal obstruction and who require parenteral hydration or nutrition
Patients who require parenteral hydration or nutrition and have evidence of partial bowel obstruction or perforation
Require parenteral nutrition
Patients with clinical symptoms or signs of gastrointestinal obstruction and who require parenteral hydration and/or nutrition.
Requires total parenteral nutrition and is unable to swallow pills or unable to take a suspension through a gastrostomy tube
Current dependency on IV hydration or total parenteral nutrition (TPN)
Subjects with clinical symptoms or signs of gastrointestinal obstruction and/or who require drainage gastrostomy tube and/or parenteral hydration or nutrition.
Participants may not have a dependency on intravenous (IV) hydration or total parenteral nutrition (TPN)
Patients requiring drainage gastrostomy (e.g., drainage percutaneous endoscopic gastrostomy [PEG] tube) and/or parenteral hydration and/or nutrition
Uncontrolled infection or significant co-morbidity (e.g., uncontrolled diabetes, severe diarrhea that requires total parenteral nutrition [TPN])
Patients with clinical symptoms or signs of gastrointestinal obstruction, require parenteral hydration or nutrition, require a drainage gastrostomy tube, and/or have any other impairment that limits their ability to take oral medication
Subject has clinical symptoms or signs of partial or complete gastrointestinal obstruction or who require parenteral hydration and/or nutrition (For cohort 3 only)
Current dependency on intravenous (IV) hydration or total parenteral nutrition (TPN)
Patients with clinical symptoms or signs of gastrointestinal obstruction and who require parenteral hydration and/or nutrition.
patients requiring total parenteral nutrition
Subject who requires parenteral nutrition, tube feeding or has evidence of partial bowel obstruction or perforation within 28 days prior to study drug administration.
Severe diarrhea (? grade 3) not controllable with medication or that requires total parenteral nutrition
Patients with signs or symptoms of gastrointestinal obstruction including those receiving total parenteral nutrition (TPN), intravenous hydration or tube feeds
Patient is currently receiving or planned to receive concurrent total parenteral nutrition and/or metoclopramide
Requirement for enteral or parenteral nutrition at time of diagnosis
Patients receiving preoperative enteral nutrition
Patients who are not fed orally (gastrostomy [G]-tube dependent, total parenteral nutrition [TPN]-dependent)
Patients with clinical symptoms or signs of gastrointestinal obstruction and/ or those who require parenteral hydration and/or nutrition; patients with history or current diagnosis of inflammatory bowel disease are not eligible
Use of growth hormone, megestrol, Marinol, or any other anabolic agents, appetite stimulants (including corticosteroids other than dexamethasone at the time of IV chemotherapy administrations), tube feeding, or parenteral nutrition during the 1 month prior to entering the study
Need of total parenteral nutrition
Ongoing parenteral nutrition (receiving intravenous nutrition support at the time of enrollment); note: patients may be receiving maintenance intravenous (IV) fluids
